Cargando…
Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
The inhibition of 5-α reductase type 2 (SRD5A2) by finasteride is commonly used for the management of urinary obstruction resulting from benign prostatic enlargement (BPE). Certain BPE patients showing no SRD5A2 protein expression are resistant to finasteride therapy. Our previous work showed that m...
Autores principales: | Lin, Zhe-Min, Fan, Dong-Dong, Jin, Song, Liu, Zhan-Liang, Niu, Yi-Nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152415/ https://www.ncbi.nlm.nih.gov/pubmed/33243958 http://dx.doi.org/10.4103/aja.aja_63_20 |
Ejemplares similares
-
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Predicting DNA Methylation State of CpG Dinucleotide Using Genome Topological Features and Deep Networks
por: Wang, Yiheng, et al.
Publicado: (2016) -
The CpG dinucleotide content of the HIV-1 envelope gene may predict disease progression
por: Wasson, Mishi Kaushal, et al.
Publicado: (2017) -
High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology
por: Lan, Xun, et al.
Publicado: (2011) -
Parvovirus B19 DNA CpG Dinucleotide Methylation and Epigenetic Regulation of Viral Expression
por: Bonvicini, Francesca, et al.
Publicado: (2012)